Roche Donations and Sponsorship

Roche Donations and Sponsorship
Basel, North West Switzerland
Web: Roche Donations and Sponsorship
Location: Basel
Discipline: Medicine/Pharmacology
Medicine Feb 8
Roche purchases shares in tender offer for Ignyta, Inc. Roche and Ignyta, Inc. today announced that Roche's wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of Ignyta, Inc.
Medicine Jan 10

Roche commences tender offer for all shares of Ignyta, Inc. for US$ 27.00 per share in cash Roche today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Ignyta, Inc.

Medicine Dec 21

European Commission approves Roche's Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer.

Medicine Dec 7

Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent for people with a type of advanced lung cancer.

Medicine Jan 4

Roche launches the cobas Plasma Separation Card to increase access to HIV testing for patients living in remote areas.

Medicine Dec 12

Roche announces phase III data showing Venclexta/Venclyxto plus MabThera/Rituxan reduced the risk of disease progression or death by 83% compared to a standard of care regimen in previously treated chronic lymphocytic leukaemia.

website preview


Medicine and Life Sciences